endo international plc (ENDP:NASDAQ GS)
Transactions by ENDO INTERNATIONAL PLC (ENDP) in the last 6 months
Endo International plc (NASDAQ:ENDP; TSX:ENL) entered into a definitive agreement to acquire Par Pharmaceutical Holdings, Inc. from TPG Global, LLC, TPG Biotechnology Partners IV, L.P. and others for $8 billion in cash and stock on May 18, 2015. Endo International will issue approximately 18 million shares of its common stock, $6.5 billion in cash and assume debt. The cash portion of the consideration is expected to be financed by a combination of cash, term loans, bonds ...
TPG Global, LLC
Endo International plc (NasdaqGS:ENDP) agreed to acquire Salix Pharmaceuticals Ltd. (NasdaqGS:SLXP) for $11 billion in cash and stock on March 11, 2015. Under this agreement Endo will acquire all of the outstanding shares of Salix common stock for per share consideration with the exchange ratio of 1.4607 and $45 payable in cash. The proposal is a 'superior proposal' to Valeant's offer. Pursuant to the transaction, one seat on the Board of Directors of the combined company ...
Deerfield Management Company, L.P.
Deerfield Partners, LP
Fidelity Management & Research Company
Franklin Resources, Inc.
HealthCor Management L.P.
Paulson & Co. Inc.
Visium Asset Management, LLC
J.P. Morgan Securities LLC
|Actelion Ltd||SFr.130.30 CHF||-0.50|
|CR Bard Inc||$197.47 USD||+0.98|
|Edwards Lifesciences Corp||$144.70 USD||-0.89|
|Hospira Inc||$89.93 USD||+0.01|
|UCB SA||€67.53 EUR||-0.23|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|